The Iraqi Society of Haematology (IQSOH) was established in 2001 with the aim of promoting and advancing the exchange of knowledge related to hematological diseases from both clinical and diagnostic perspectives. The Society serves as a professional platform that brings together Iraqi hematologists, specialists in clinical and laboratory medicine, and physicians involved in the practice of hematology in Iraq and abroad. The Society was founded through the efforts of several distinguished Iraqi hematologists from both clinical and laboratory departments, including Dr. Mayada Alnuaimi, Dr. Ferial Hemli, Dr. Ali Moslem, Dr. Fouad Alkasab, Dr. Ali Mohammed Jawad, Dr. Azhar Sabeeh, and Dr. Abdul-Majeed Alwan. Between 2003 and 2005, due to major governmental changes in Iraq, the Society’s activities were temporarily suspended. In 2006, activities resumed following the re-election of members, and Dr. Nabeel Salman was elected as President of the Iraqi Society of Hematology. The Society continued its scientific and professional activities until December 2018, when it received official approval from the Iraqi Ministry of Higher Education and Scientific Research to reactivate and legally re-establish the Society. A subsequent election was conducted to select the Society’s president and members for the 2019–2023 term.
Our Mission
The mission of the Iraqi Society of Haematology is to advance knowledge in the diagnosis, treatment, and prevention of hematological diseases and to promote excellence in the practice of hematology and transfusion medicine in Iraq.
To accomplish this mission, the Society aims to:
1. Advance knowledge and clinical practice in hematology and transfusion medicine.
2. Promote research, professional training, and scientific interest in hematology across the country.
3. Organize and support educational activities and scientific events related to the recognition, treatment, and prevention of hematological disorders.
4. Contribute actively to medical education at all levels.
5. Collaborate with local and international medical and hematological societies, as well as professional organizations, in both basic and clinical research.
6. Improve diagnostic technologies and clinical practice across different healthcare settings.
7. Strengthen communication between academic research institutions and public health sectors.
8. Support the development of hematology education and practice throughout Iraq.
9. Promote the standardization of hematological diagnostic methods and clinical guidelines.
Our Vision
Working together to achieve excellence in patient care, education and research in hematology in Iraq.
Bylaw
Message from the President of ISOH
Dear Esteemed Members of the Iraqi Society of Hematology,
Over the years, ISOH has made continuous efforts to strengthen both clinical practice and scientific research across the diverse disciplines related to hematology, including internal medicine, pediatrics, laboratory medicine, pathology, and the basic medical sciences. Close interdisciplinary collaboration remains essential for progress in hematology and will continue to be a cornerstone of our future development.
ISOH strives to provide a strong platform for professional collaboration, knowledge exchange, and joint research initiatives among specialists. In addition to scientific activities, the Society is committed to increasing public awareness of hematological diseases and emphasizing the importance of early diagnosis and appropriate treatment.
The Society also actively supports improvements in healthcare systems and policies that promote the advancement of hematology practice in Iraq. Since 2006, ISOH has organized the 1st Annual Conference and National Meeting of the Iraqi Society of Haematology. These events have become important platforms for scientific exchange, professional development, and strengthening the Society’s presence within the medical community. We sincerely appreciate your continued engagement, participation, and support as we work together to advance the Society through collaboration in patient care, training, and research among all ISOH members. Thank you for your continued support.
